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ABSTRACT
Synthetic RNA duplexes that are substrates for Dicer
are potent triggers of RNA interference (RNAi). Blunt
27mer duplexes can be up to 100-fold more potent
than traditional 21mer duplexes (1). Not all 27mer
duplexes show increased potency. Evaluation of
the products of in vitro dicing reactions using elec-
trospray ionization mass spectrometry reveals that
a variety of products can be produced by Dicer cleav-
age. Use of asymmetric duplexes having a single
2-base 30-overhang restricts the heterogeneity that
results from dicing. Inclusion of DNA residues at
the ends of blunt duplexes also limits heterogeneity.
Combination of asymmetric 2-base 30-overhang with
30-DNA residues on the blunt end result in a duplex
form which directs dicing to predictably yield a single
primary cleavage product. It is therefore possible to
design a 27mer duplex which is processed by Dicer to
yield a specific, desired 21mer species. Using this
strategy, two different 27mers can be designed that
result in the same 21mer after dicing, one where the
30-overhang resides on the antisense (AS) strand and
dicing proceeds to the ‘right’ (‘R’) and one where the
30-overhangresides onthesense (S)strandanddicing
proceeds to the ‘left’ (‘L’). Interestingly, the ‘R’ version
of the asymmetric 27mer is generally more potent in
reducing target gene levels than the ‘L’ version 27mer.
Strand targeting experiments show asymmetric
strand utilization between the two different 27mer
forms, with the ‘R’ form favoring S strand and the
‘L’ form favoring AS strand silencing. Thus, Dicer
processing confers functional polarity within the
RNAi pathway.
INTRODUCTION
RNA interference (RNAi) is a conserved pathway present
in most eukaryotes where double-stranded RNA (dsRNA)
triggers a series of biochemical events that culminates in
sequence-specific suppression of gene expression (2–4).
Long dsRNAs have been employed for many years as a means
to modulate gene expression in plants (5), yeast (6) and
Caenorhabditis elegans (7). Similar attempts in mammalian
cells failed due to interferon activation. In Drosophila, dsRNA
of >150 bp length efficiently induces an RNAi response. This
response becomes weaker as RNA length decreases and
25–38 bp duplexes are inactive; very short duplexes of 19–
23 bp length regain activity (8). The biochemistry is slightly
different in mammalian cells and 25–30 bp duplexes will
strongly induce an RNAi response, but potency does decrease
with length and 45 bp duplexes are mostly inactive (1). In vivo,
long dsRNAs are cleaved by the RNase III class endoribo-
nuclease Dicer into 21–23 base duplexes having 2-base
30-overhangs (9,10). These species, called ‘small interfering
RNAs’ (siRNAs), enter the RNA induced silencing complex
(RISC) and serve as a sequence-specific guide to target
degradation of complementary mRNA species (8).
The discovery of siRNAs permitted RNAi to be used as an
experimental tool in higher eukaryotes. Typically, siRNAs are
chemically synthesized as 21mers with a central 19 bp duplex
region and symmetric 2-base 30-overhangs on the termini.
These duplexes are transfected into cells lines, directly mim-
icking the products made by Dicer in vivo. Most siRNA
sequences can be administered to cultured cells or to animals
without eliciting an interferon response (11–13). There are
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some reports that particular motifs can induce such a response
when delivered via lipids (13–15), although a cyclodextrin-
containing polycation system has been shown to deliver
siRNA containing one such putative immunostimulatory
motif that achieves target gene down-regulation in mice
without triggering an interferon response (16), even in a
disseminated tumor model.
RNAi has rapidly become the favored method to knock
down single genes for detailed study or hundreds to thousands
of genes in high-throughput functional genomics surveys. The
potential of 21mer siRNAs for use as therapeutic agents to
reduce activity of specific gene products is also receiving
considerable attention and successful knockdown of gene
expression in mice has already been demonstrated by several
groups (17–20).
We recently described that chemically synthesized RNA
duplexes of 25–30 base length can have as much as a
100-fold increase in potency compared with 21mers at the
same location. At the site most extensively examined in this
study, EGFPS1, only minor differences in potency were seen
between duplexes with blunt, 30-overhang or 50-overhang ends,
and a blunt 27mer duplex was most potent (1). Increased
potency has similarly been described for 29mer stem short
hairpin RNAs (shRNAs) when compared with 19mer stem
hairpins (21). While the primary function of Dicer is generally
thought to be cleavage of long substrate dsRNAs into short
siRNA products, Dicer also introduces the cleaved siRNA
duplexes into nascent RISC in Drosophila (22–24). Dicer is
involved in RISC assembly and is itself part of the pre-RISC
complex (25). The observed increased potency obtained using
longer RNAs in triggering RNAi is theorized to result from
providing Dicer with a substrate (27mer) instead of a product
(21mer) and that this improves the rate or efficiency of entry
of the siRNA duplex into RISC.
Unfortunately, not all 27mers show this kind of increased
potency. It is well known that shifting a 21mer siRNA by a
few bases along the mRNA sequence can change its potency
by 10-fold or more (26–28). Different products that result from
dicing can have different functional potency, and control of
the dicing reaction may be necessary to best utilize Dicer–
substrate RNAs in RNAi. The EGFPS1 blunt 27mer studied in
Kim et al. (1) is diced into two distinct 21mers. Vermeulen
and colleagues reported studies where synthetic 61mer duplex
RNAs were digested using recombinant human Dicer in vitro
and examined for cut sites using a 32P-end-labeled gel assay
system. Heterogeneous cleavage patterns were observed and
the presence of blunt versus 30-overhang ends altered precise
cleavage sites (29). Dicing patterns for short 25–30mer RNA
substrates have not been published and processing rules that
enable accurate prediction of these patterns do not exist. We
therefore studied dicing patterns at a variety of sites using
different duplex designs to see if cleavage products could
be predicted. We find that a wide variety of dicing patterns
can result from blunt 27mer duplexes. An asymmetric duplex
having a single 2-base 30-overhang generally has a more pre-
dictable and limited dicing pattern where a major cleavage site
is located 21–22 bases from the overhang. Including DNA
residues at the 30 end of the blunt side of an asymmetric duplex
further limits heterogeneity in dicing patterns and makes it
possible to design 27mer duplexes that result in predictable
products after dicing.
We find that position of the 30-overhang influences
potency and asymmetric duplexes having a 30-overhang on
the antisense strand are generally more potent than those
with the 30-overhang on the sense strand. This can be attri-
buted to asymmetrical strand loading into RISC, as the
opposite efficacy patterns are observed when targeting the
antisense transcript. Novel designs described here that
incorporate a combination of asymmetric 30-overhang with
DNA residues in the blunt end offer a reliable approach to




All RNA oligonucleotides described in this study were
synthesized and purified using high-performance liquid
chromatography (HPLC) at Integrated DNA Technologies
(Coralville, IA). All oligonucleotides were examined by elec-
trospray ionization mass spectrometry (ESI-MS) and were
within ±0.02% predicted mass and were further examined
by capillary electrophoresis and were >90% molar purity.
Final duplexes were prepared in sodium salt form. Duplexes
are named by site (EGFPS2 is Site 2 in enhanced green fluor-
escent protein) and by strand length. EGFPS2 27/27 is a blunt
27mer RNA duplex. EGFPS2 25/27 has a 25 base top (sense,
‘S’) strand and 27 base bottom (antisense, ‘AS’) strand with a
2-base 30-overhang. EGFPS2 27/25 has a 27 base sense strand
with a 2-base 30-overhang and a 25 base antisense strand.
DNA bases have been substituted at various locations and
inclusion is indicated as ‘D’ in compound names and DNA
residues are identified using bold lower case letters in
sequence; ‘p’ represents 50-phosphate. Starting with a 21mer
sequence, an ‘R’ 27mer has added bases extending to the right
side of this sequence (30 with respect to the target) and an ‘L’
27mer has added bases extending to the left side of this
sequence (50 with respect to the target). All RNA duplexes
used in this study are listed in Table S1 (online Supplementary
Material).
In vitro dicing assays
RNA duplexes (100 pmol) were incubated in 20 ml of 20 mM
Tris, pH 8.0, 200 mM NaCl, 2.5 mM MgCl2 with or without
1 U of recombinant human Dicer (Stratagene, La Jolla, CA)
at 37C for 24 h. Samples were desalted using a Performa SR
96 well plate (Edge Biosystems, Gaithersburg, MD). Electro-
spray ionization liquid chromatography mass spectroscopy
(ESI-LC-MS) of duplex RNAs pre- and post-treatment
with Dicer were done using an Oligo HTCS system (Novatia,
Princeton, NJ) (30), which consisted of ThermoFinnigan
TSQ7000, Xcalibur data system, ProMass data processing soft-
ware and Paradigm MS4 HPLC (Michrom BioResources,
Auburn, CA). The liquid chromatography step employed
before injection into the mass spectrometer (LC-MS) removes
most of the cations complexed with the nucleic acids; some
sodium ion can remain bound to the RNA and are visualized as
minor +22 or +44 species, which is the net mass gain seen with
substitution of sodium for hydrogen. All dicing experiments
were performed at least twice.
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EGFP RNAi assays
HEK 293 cells were split in 24-well plates to 60% confluency
in DMEM media one day prior to transfection. The indicated
amounts of reporter and internal control DNAs and siRNAs
were diluted in 50 ml of Opti-MEM I (Invitrogen, Carlsbad,
CA) and mixed with 50 ml of Opti-MEM I diluted Lipofectam-
ine 2000 (1 ml per well) (Invitrogen). After incubation at room
temperature for 20–30 min, the complexes were added to cells
in 0.4 ml of DMEM media. To normalize for transfection
efficiency, either firefly luciferase or red fluorescent protein
(RFP) reporter plasmids were included as internal controls.
For the luciferase assay, the Steady Glo Luciferase Assay Kit
(Promega, Madison, WI) was used according to manufacturer’s
instruction. For RFP co-transfection, the indicated amount of
EGFP reporter plasmid (pLEGFP-C1 vector, Clontech, Palo
Alto, CA) was co-transfected with 20 ng of RFP reporter
plasmid (pDsRed2-C1, BD Sciences, Franklin Lakes, NJ).
After 24 h, RFP expression levels were monitored by fluor-
escence microscopy. Only experiments where transfection
efficiencies were >90% (as assessed by RFP expression)
were evaluated. Levels of EGFP expression were measured
24 h later. EGFP expression was determined either from the
median number of EGFP-fluorescent cells determined by
FACS (live cells) or by fluorometer readings (cell extracts).
All transfections were minimally performed in duplicate and
data averaged. Assays done in triplicate (or more) include
error bars in data reporting.
EGFP reporter assays of hnRNPH RNAi
To facilitate throughput, efficacy of hnRNPH-specific
duplexes were assayed using a synthetic reporter system where
the complete coding region of the hnRNPH gene was cloned
into the XhoI and BamHI sites of the EGFP gene in the expres-
sion vector pLEGFP-C1 (Clontech, Palo Alto, CA) to make an
EGFP-hnRNPH fusion protein. A PCR product was made
from a human hnRNPH cDNA clone using the XhoI contain-
ing forward primer 50-ACGCAGAACTCGAGTGTCTA-30
and the BamHI containing reverse primer 50-TCACTGCTCC-
TAGGTTACCT-30. The resulting PCR product was digested
using XhoI and BamHI, and cloned into pLEGFP-C1 that
had been similarly digested. Products were verified by DNA
sequencing. The fusion protein reporter construct was used to
directly measure activity of anti-hnRNPH reagents by change
in EGFP fluorescence (31). Transfection and EGFP assays
were performed as described above.
Firefly luciferase RNAi assays
HeLa cells were seeded at 5e4 cells per well in 24-well plates
24 h prior to transfection in DMEM (Mediatech, Herndon,
VA) containing 10% fetal bovine serum (Invitrogen). In
each well, 100 ml of OptiMEM I containing 2.5 ml Lipofectam-
ine was added to an equal volume of OptiMEM I containing
1 mg pGL3-Control Vector (Promega), and the indicated
duplex at either 20, 2 or 0.4 nM and incubated at room tem-
perature for 30 min prior to transfection. Plates were washed
with PBS and incubated for 4 h at 37C with lipoplex solution.
Lipoplex solutions were replaced with 1 ml complete growth
medium. At 48 h post-transfection, growth medium was
replaced with 100 ml 1·Cell Culture Lysis Reagent (Promega).
Plates were incubated at room temperature with gentle shaking
for 1 h to allow complete cell lysis. The luminescence of cell
lysates was determined using a Monolight 3010 luminometer
(BD Pharmingen, San Diego, CA) and the Luciferase assay
system (Promega). Substrate solution (100 ml) was added to
10 ml cell lysate, and the resulting luminescent signal was
integrated over 10 s. Results are presented in relative light
units (RLU) as a percentage of the average signal for plasmid-
only samples on the same plate. Mean and SD values for
triplicate wells are presented for all treatments.
La RNAi assays
RNA duplexes specific for the human La antigen
(NM_003142) were transfected into HEK293 cells in 6-well
plates at 30% confluency as described above. Cellular extracts
were prepared 72 h post-transfection. Western blots were per-
formed as described previously (1). The anti-Enolase antibody
was obtained from Biogenesis (Kingston, NH) and the anti-La
antibody was kindly provided by Dr Ger Pruijn (Katholieke
Universiteit Nijmergen, Netherlands).
HeLa cells were split in 24-well plates at 35% confluency
and were transfected the next day with Oligofectamine (Invit-
rogen) using 1 ml per 65 ml OptiMEM I with RNA duplexes at
the indicated concentrations. All transfections were performed
in triplicate. RNA was harvested at 24 h post-transfection
using SV96 Total RNA Isolation Kit (Promega). RNA was
checked for quality using a Bioanalyzer 2100 (Agilent, Palo
Alto, CA) and cDNA was prepared using 500 ng total RNA
with SuperScript-II reverse transcriptase (Invitrogen) per
manufacturer’s instructions using both oligo-dT and random
hexamer priming. Real-time PCRs were done using an estim-
ated 33 ng cDNA per 25 ml reaction using Immolase DNA
Polymerase (Bioline, Randolph, MA) and 200 nM primers
and probe. La-specific primers were La-For 50-GACCAACA-
AGAATCCCTAAACA, La-Rev 50-CTTGCCCTGAAACT-
GTACTT and probe La-P 50-FAM-AAGGGTAATAAAGC-
TGCCCAGCCTGGGT-IowaBlackFQ. Cycling conditions
employed were as follows: 50C for 2 min and 95C for
10 min followed by 40 cycles of 2-step PCR with 95C for
15 s and 60C for 1 min. PCR and fluorescence measurements
were done using an ABI Prism 7000 Sequence Detector
(Applied Biosystems Inc., Foster City, CA). All data points
were performed in triplicate. Expression data was normalized
to internal control human acidic ribosomal phosphoprotein
P0 (RPLP0) (NM_001002) levels which were measured
in separate wells in parallel using primers RPLP0-For
50-GGCGACCTGGAAGTCCAACT, RPLP0-Rev 50-CCAT-
CAGCACCACAGCCTTC, and probe RPLP0-P 50-FAM-
ATCTGCTGCATCTGCTTGGAGCCCA-IowaBlackFQ (32).
Luciferase reporter vectors with EGFP and
hnRNPH, S versus AS targeting
A PCR generated fragment of the EGFP coding region span-
ning sites EGFPS1 and EGFPS2 was cloned into the XhoI site
located in the 30-untranslated region (30-UTR) of the human-
ized Renilla luciferase gene of plasmid psiCHECK-2
(Promega). Primers containing an XhoI restriction site and
EGFP nucleotides 67–85 (For, 50-TTTCTCGAGGTAAACGG-
CCACAAGTTCA-30) and 291–311 (Rev, 50-TTTCTCGAG-
TCGTCCTTGAAGAAGATGGTG-30) were used to generate
a 245 bp EGFP PCR product. The PCR product was digested
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with XhoI and the fragment was cloned into a unique XhoI
site located in the psiCHECK-2 vector. Clones with both
orientations (S and AS) were obtained and verified by DNA
sequencing.
A PCR generated fragment of the hnRNPH coding region
spanning sites H1 and H3 was similarly cloned into the XhoI
site located in the 30-UTR of the humanized Renilla luciferase
gene of plasmid psiCHECK-2. The fragment was 343 bp
long including the region 90–432 of reference sequence
NM_005520. Clones with both orientations (S and AS)
were obtained. Maps of the ‘S’ and ‘AS’ psiCHECK-2 reporter
vectors are shown in Figure S2 in the Supplementary Material.
HEK293 cells were transfected with 150 ng of reporter
vectors Luc-EGFP-‘S’ or Luc-EGFP-‘AS’ with the indicated
amounts of EGFPS2 or control duplex RNAs as described
above. HCT116 cells were transfected with 100 ng of reporter
vectors Luc-hnRNPH-‘S’ or Luc-hnRNPH-‘AS’ with the
indicated amounts of H3 or control duplex RNAs. Luciferase
assays were performed 24 h post-transfection. Changes
in expression of Renilla luciferase (target) were calculated
relative to firefly luciferase (internal control).
RESULTS
Dicing patterns for EGFP RNA duplexes
The products that result from in vitro digestion of various
substrate RNA duplexes with recombinant human Dicer
were visualized using ESI-MS (hereafter referred
to as the ‘ESI-dicing assay’). A blunt 27mer derived from
EGFP Site-1 (EGFPS1) was previously shown to produce
two primary 21mer cleavage products by ESI-dicing (1).
RNA duplexes derived from EGFP Site 2 (EGFPS2) sequence
are studied here in greater detail and are shown in
Figure 1 and Figure S1 (online Supplementary Material). In
general, in vitro dicing of 27mer duplexes using recombinant
human Dicer results in a heterogeneous set of products, most
of which are 21mer or 22mer species with 50-phosphate. More
rarely, 20mer and 23mer species are also seen; these species
are usually inconsistent between repetitions. If a cleavage
product includes the 50 end from the original chemically syn-
thesized substrate duplex (i.e. no enzymatic cleavage event
was needed to produce that end), the 50 end of the diced
product remained identical to the substrate (50-phosphate or
50-OH). 50 ends resulting from internal cleavage events show
mass values consistent with the presence of 50-phosphate. This
spectrum of diced products is consistent with the pattern seen
by Elbashir in a collection of sequenced clones derived from
diced longer dsRNAs (8). Peaks seen in a mass spectrometry
trace can sometimes be identified to represent a single, unam-
biguous, unique sequence. In other cases, it is not possible to
unambiguously identify a specific sequence based solely upon
mass if more than one 21mer with same base composition (and
therefore the same mass) could be produced from cleavage of
the substrate 27mer. In deconvolution of the mass spectra data,
we have assigned duplex identity to unique species wherever
possible and otherwise have identified products which are
consistent with 21mer or 22mer duplexes with 2-base 30-over-
hangs (instead of other combinations that would yield blunt
duplexes or 1-base overhangs, etc.).
ESI-dicing of the blunt 27mer substrate duplex EGFPS2 R
27/27 shows a variety of mass peaks which are consistent with
five duplex products, shown in Figure 1A. Using other blunt
27mer duplex sequences (from other sites), we have seen 2, 3,
4 or more duplex products result from dicing (data not shown).
Elbashir reported in vitro dicing of 39, 52 and 111 bp dsRNA
substrates using Drosophila extracts. Products were cloned
and a heterogeneous collection of 21–22 base fragments
were identified by DNA sequencing. While dicing appeared
to generally initiate from one or both ends, no single product
or subset of products was dominant (8). We cannot identify
any obvious pattern that allows prediction of what specific
21mer(s) will result from dicing a given blunt 27mer, making
rational design of 27mer RNAi reagents difficult. We therefore
tested a series of design variants to see if this heterogeneity
could be reduced with the goal of finding a design for which
cleavage patterns could be reliably predicted.
Modification of one end of a blunt 27mer duplex with
fluorescein inhibits dicing. Modification of both 30 ends
with fluorescein completely blocks dicing (1). We tested if
substitution of three DNA residues at the 50 or 30 end of either
strand of a blunt 27mer duplex affected dicing patterns.
Results are shown in Figure S1 (online Supplementary
Material). DNA residues cannot be cleaved by Dicer and
therefore directly alter cleavage patterns. Further, the DNA
residues seem to reduce the likelihood of Dicer binding
that end (assuming that Dicer binds the RNA duplex via
the PAZ domain and then cuts 21–22 bases away) (33), espe-
cially when positioned on the 30 end. Curiously, EGFPS2 R
27/27(30D), the duplex with DNA residues positioned at the
30 end of the antisense strand, was not diced to produce any
21–22mer cleavage product (identical results were obtained in
three attempts). While the use of terminal DNA residues can
change and somewhat simplify dicing patterns, this approach
alone is insufficient to truly direct dicing to predictable
patterns.
Naturally occurring substrates for Dicer include micro-
RNAs (miRNAs). These species typically originate in the
nucleus as long primary transcripts where they are processed
to 70mer pre-miRNAs by the RNase III class endonuclease
Drosha (34,35). Drosha products are shRNAs, which structur-
ally look like an asymmetric duplex, having a single 2-base
30-overhang on one side and a hairpin loop on the other side.
These species are exported to the cytoplasm (36) where final
processing by Dicer takes place (37). The 30-overhang may
be important for Dicer processing. The presence of a single
2-base 30-overhang has been shown to help direct ‘correct’
dicing of synthetic shRNAs (21) and alters dicing patterns of
synthetic linear 61mer duplexes (29).
Asymmetric duplexes having one 2-base 30-overhang
and one blunt end were studied using the ESI-dicing assay.
Duplex EGFPS2 R 25/27 has two bases removed from the
50 end of the sense strand compared with blunt duplex
EGFPS2 R 27/27, providing a single 2-base 30-overhang.
This duplex showed a much simplified dicing pattern,
Figure 1B. Only one 21mer and one 22mer duplex were pro-
duced. The observed pattern is consistent with a model where
Dicer binds the 30-overhang of the substrate RNA and cleavage
takes place 21–22 bases distant from this site (33). In fact,
this pattern could be considered a single event as dicing gen-
erates a single pair of related duplexes as ‘the product’ made
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from digestion of the substrate duplex from a single unique
binding or start site.
The presence of a 30-overhang does not always restrict
dicing to a simple pattern. Duplex EGFPS2 R 27/25 has
two bases removed from the 50 end of the antisense strand
compared with blunt duplex EGFPS2 R 27/27. This duplex
showed a complex dicing pattern (Figure 1C) which is
different from both the parent blunt duplex (Figure 1A)
and the asymmetric duplex with the 30-overhang on the oppos-
ite end (Figure 1B). Changing the bases present on the
30-overhang from ‘CC’ to ‘GG’ did not reduce the complexity
of dicing pattern seen for this duplex (data not shown).
The two approaches of modifying dicing patterns were com-
bined and DNA residues were placed at the 30 end (blunt end)
of the antisense strand of asymmetric duplex EGFPS2 R 27/25,
resulting in duplex EGFPS2 R 27/25D. This duplex gave a
simplified dicing pattern with only a single 21mer and a single
22mer species (Figure 1D). This new design strategy places an
element on one end that is generally favorable for Dicer
binding (2-base 30-overhang) and an element on the other
A
B
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end that is generally unfavorable for Dicer binding (blunt end
with 30-DNA residues). This type of duplex appears to offer
Dicer a single favorable binding site and would be predicted to
result in a single 21mer product.
Dicing patterns from the new design having a 2-base
30-overhang on one end and blunt with 30-DNA residues on
the other end were examined using additional duplexes.
Duplex EGFPS2 R 25D/27 has a 30-overhang on the antisense
strand and two DNA bases at the 30 end (blunt end) of the sense
strand. Duplex EGFPS2 L 27/25D has the opposite design
with a 30-overhang on the sense strand and two DNA bases
at the 30 end (blunt end) of the antisense strand. If the design
strategy works as predicted, these two different duplexes
should both be diced into the same 21mer product. EGFPS2
R 25D/27 diced into the expected 21mer/22mer pair with
cleavage of 21–22 bases from the 30-overhang (Figure 1E).
Similarly, EGFPS2 L 27/25D diced into the expected 21mer/
22mer pair with cleavage 21–22 bases from the 30-overhang
(Figure 1F). Thus, the same 21mer duplex was produced from
two different substrate RNAs. Note, however, that the sister
product (22mer) is necessarily different for each substrate
since the single base addition occurs on opposite sides of
the 21mer.
To confirm that this cleavage pattern holds at other sites
and is truly predictable, a similar related pair of asymmetric
27mers were tested at EGFP Site-1 (Supplementary Table S1).
C
D
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EGFPS1 R 25D/27 diced into the expected 21mer duplex with
cleavage 21 bases from the 30-overhang (Figure 1G). In this
instance, no 22mer was seen. Similarly, EGFPS1 L 27/25D
diced into the expected 21mer/22mer pair with cleavage of
21–22 bases from the 30-overhang (Figure 1H). Again, the
same 21mer duplex was produced from two different 27mer
substrate RNAs.
Functional potency is different for ‘R’
versus ‘L’ form RNA duplexes
EGFPS2 duplexes were co-transfected into HEK293 cells
with an EGFP expression plasmid. The blunt 27mer duplex
(EGFPS2 R 27/27) was more potent in reducing EGFP expres-
sion levels than the 21mer duplex (EGFPS2 21/21) (1). The
L 27/25D asymmetric duplex was slightly less potent than
the blunt 27mer while the R 25D/27 asymmetric duplex
was significantly more potent than any other duplex tested at
the EGFPS2 site (Figure 2A). A similarly matched pair of
asymmetric 27mer duplexes was studied at EGFP Site-1
(Figure 2B). As was observed previously for the EGFPS2 site,
the ‘R’ asymmetric duplex was significantly more potent than
the ‘L’ asymmetric duplex.
We originally expected that the ‘R’-form and ‘L’-form
duplexes would have similar functional potency since both
result in the same antisense 21mer product after dicing
(EGFPS2, Figure 1E and F; EGFPS1, Figure 1G and H).
The ‘L’ and ‘R’ duplexes do produce different 22mer products
after dicing. It is possible that the differential potency relates
to these 22mer products. To test this possibility directly,
RNA duplexes of 22mer length that correspond to the products
identified from ESI-dicing of the ‘L’ and ‘R’-form 27mers
for both EGFPS1 and EGFPS2 were co-transfected into
HEK293 cells with an EGFP expression plasmid. For site
E F
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EGFPS2, the ‘R-derived’ 22mer was significantly more potent
than the ‘L-derived’ 22mer. This species could contribute to
the higher potency observed for the ‘R’ form EGFPS2 27mer.
However, for site EGFPS1 the ‘L-derived’ 22mer was 3-fold
more potent than the ‘R-derived’ 22mer (Supplementary
Figure S3). In this case, 22mer products cannot contribute
to the observed higher potency of the ‘R’ form EGFPS1
27mer. Therefore, although the different 22mer species that
result from 27mer dicing can contribute to the ultimate
potency of a given duplex, we believe that the generalized
difference in potency seen between ‘R’ and ‘L’-form 27mers
results from other aspects of Dicer/RISC biochemistry.
Vermeulen reported that asymmetric 21mer duplexes with a
single 30-overhang on the antisense strand were generally
more potent than duplexes with a single 30-overhang on
the sense strand (for 3 out of 4 duplexes studied in one
gene target) (29). In this case, the duplexes tested were not
Dicer substrates.
Dicer–substrate duplexes were studied in other target
systems to see if the seeming functional asymmetry between
duplexes that are processed to the same 21mer product was
reproducible at additional sites. RNA duplexes targeting two
adjacent sites in the hnRNPH gene were tested for potency
in triggering RNAi. Site H3 and neighboring site H1 (two
base 50-shift) were studied for RNAi-mediated suppression
of EGFP fluorescence using a modified EGFP expression
G
H
Figure 1. ESI-MS analysis of in vitro dicing reactions. Mass spectra of duplexes are shown before (top) and after (middle) digestion with recombinant human
Dicer. Sequence of the substrate RNA duplex is provided with detected cleavage products along with calculated molecular weight and strand length (bottom). RNA
bases are upper case, DNA bases are lower case bold and ‘p’ represents 50-phosphate. (A) Blunt duplex EGFPS2 R 27/27; (B) asymmetric duplex EGFPS2 R 25/27;
(C) asymmetric duplex EGFPS2 R 27/25; (D) asymmetric duplex EGFPS2 R 27/25(30D); (E) asymmetric duplex EGFPS2 R 25D/27; (F) asymmetric duplex
EGFPS2 L 27/25D; (G) asymmetric duplex EGFPS1 R 25D/27; (H) asymmetric duplex EGFPS1 L 27/25D.
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construct that includes the complete hnRNPH coding sequence
fused in frame with the C-terminal end of EGFP. RNA
duplexes were co-transfected into HEK293 cells with the
EGFP-hnRNPH reporter vector and EGFP expression was
measured at 48 h (Figure 2C). The ‘L’ duplex H3 L 27/25D
showed similar potency to the H3 21mer duplex while the ‘R’
duplex H3 R 25D/27 was markedly more potent. The same
trend was observed at site H1. The ‘L’ duplex H1 L 27/25D
had similar potency to the H1 21mer duplex while the ‘R’
duplex H1 R 25D/27 was markedly more potent. Thus, at both
these new sites, the ‘R’ version of the asymmetric 27mer
duplex was found to be significantly more potent than the
‘L’ version duplex. It is also interesting to note the large
difference in potency seen between the H1 and H3 21mers
even though these duplexes are shifted by only two bases along
the hnRNPH sequence.
Asymmetric ‘R’ and ‘L’ version RNA duplexes targeting
four sites in firefly luciferase were compared for potency in
triggering RNAi. Duplexes were co-transfected with a luci-
ferase reporter vector into HeLa cells and cell extracts were
D E
Figure 2. ‘R’ form duplexes are more potent than ‘L’ form duplexes. Top: relative expression data are shown. Bottom: target sequences (S strand) are shown and
transfected RNAi duplexes are aligned beneath in duplex form with sense strand top (50!30) and antisense strand bottom (30!50). RNA bases are upper case, DNA
bases are lower case bold, and ‘p’ represents 50-phosphate. (A) Relative EGFP fluorescence was measured following co-transfection of an EGFP expression plasmid
and EGFPS2 RNA duplexes; (B) relative EGFP fluorescence was measured following co-transfection of an EGFP expression plasmid and EGFPS1 RNA duplexes;
(C) relative EGFP fluorescence was measured following co-transfection of an EGFP-hnRNPH fusion vector and hnRNPH RNA duplexes; (D) relative light emission
from firefly luciferase was measured following co-transfection of a luciferase expression vector and luciferase RNA duplexes; (E) RNA duplexes specific for La
antigen mRNA were transfected into cells at 2.5 nM concentration and protein extracts were prepared 72 h post-transfection. Western blots were done using anti-La
antibodies and anti-enolase (control) antibodies. RNA duplexes were transfected into cells at 1, 2.5 and 10 nM concentrations, and RNA was prepared 24 h
post-transfection. Quantitative real-time RT–PCR was used to measure relative La mRNA levels, using RPLP0 as an internal normalization standard.
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examined for suppression of luciferase light emission 48 h
post-transfection (Figure 2D). At sites Luc-1 and Luc-3, the
‘R’ 27mer duplex was more potent than the ‘L’ 27mer duplex
at all doses. At sites Luc-2 and Luc-4, the two forms were of
similar potency at 10 and 1 nM, while the ‘L’ form duplexes
were slightly more effective than the ‘R’ form at 200 pM.
To ensure that the functional polarity observed between
‘R’ versus ‘L’ Dicer–substrate RNAs was not an artifact
of targeting synthetic reporter constructs, we targeted an
endogenous transcript, the La protein encoding mRNA
(NM_003142). We previously described that a blunt 27mer
Dicer–substrate duplex was more potent at reducing expres-
sion of La mRNA than a 21mer duplex at the same site (1).
‘R’ and ‘L’ form asymmetric 27mer Dicer–substrate duplexes
at this same site and were transfected into HEK293 cells at
various concentrations. Protein extracts were prepared 72 h
post-transfection and examined for La expression levels by
western blot analysis (Figure 2E). The ‘L’-sided duplex
showed little if any suppression at 2.5 nM dose whereas the
‘R’-sided duplex showed appreciable inhibition. The same La
duplexes were transfected into HeLa cells and RNA was pre-
pared at 24 h post-transfection. La mRNA levels were assayed
using a quantitative real-time RT–PCR assay (Figure 2E). The
‘R’-sided duplex was more potent than the ‘L’-sided duplex at
reducing La mRNA levels at all doses examined. Therefore,
the same functional polarity is observed when targeting an
endogenous transcript as previously observed using plasmid
reporter constructs.
In summary, ‘R’ duplexes (30-overhang on the antisense
strand) were more active in triggering RNAi than ‘L’ duplexes
(30-overhang on the sense strand) at 7 out of 9 sites studied here
using 27mer Dicer–substrate duplexes and for 3 out of 4 21mer
duplexes reported by Vermeulen (29). The impact that end
stability can have on 21mer duplex entry into RISC has been
well described (28,38–40) and is a cornerstone for current
siRNA design rules. New asymmetric terminal overhang
rules may offer an additional basis for rational design of
siRNAs.
‘L’ versus ‘R’ dicing polarity influences
strand targeting
It is possible that functional polarity is introduced by the
direction that dicing proceeds relative to the sense and anti-
sense strands of the substrate RNA, and that this somehow
influences strand entry into RISC. We directly tested this
possibility using a synthetic reporter vector system where
suppression of both sense and antisense strands target mRNA
could be independently assayed. A fragment of the EGFP
coding region that spans EGFP Site 2 was cloned into the
30-UTR of the Renilla luciferase gene in the psiCHECK-2
vector in both orientations, producing a sense reporter vector,
Luc-EGFPS-‘S’, and an antisense reporter vector, Luc-EGFP-
‘AS’. Maps of ‘S’ versus ‘AS’ reporter constructs are shown
in Figure S2 in the Supplementary Material. Inhibition of
Luc-EGFP-‘S’ is an assay for functional loading of the anti-
sense strand of the siRNA into RISC. Conversely, inhibition
of Luc-EGFP-‘AS’ is an assay for functional loading of the
sense strand of the siRNA into RISC.
The sense and antisense reporter vectors were co-
transfected into HEK293 cells with various concentrations
of EGFPS2 RNA duplexes and luciferase activity was assayed
24 h post-transfection (Figure 3A). All duplexes showed better
inhibition of luciferase expression using the ‘S’ than the ‘AS’
orientation EGFP target, as would be expected for a ‘good’
A
B
Figure 3. Strand bias is introduced by the direction of Dicer processing.
Reporter constructs were made in the psiCheck-2 vector that contained a
fragment of EGFP or hnRNPH coding sequence cloned into the 30-UTR of the
Renilla luciferase gene in both ‘S’ and ‘AS’ orientations. Reporter plasmids
were co-transfected into cells without (control) or with the indicated RNA
duplexes and luciferase activity was measured 24 h post-transfection. Results
are reported as the ratio of Renilla luciferase (target) to firefly luciferase
(internal control); (A) EGFP strand targeting; (B) hnRNPH strand targeting.
Schematic diagrams of the four synthetic reporter constructs employed with
orientation of target sequences relative to Renilla luciferase are shown.
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functional siRNA site, and both 27mers were more potent than
the 21mer duplex. Preferential targeting of the sense reporter
was observed for both ‘R’ and ‘L’ form duplexes, however
relative inhibition of the antisense reporter was substantially
better for the ‘L’ form duplex, indicating relative increased
loading of the sense (top) strand of the ‘L’ form siRNA into
RISC. Even though the same 21mer results from dicing
(Figure 1E and F), the ‘L’ and ‘R’ form duplexes clearly show
different patterns of ‘S’ versus ‘AS’ strand targeting.
A fragment of the hnRNPH genes that spans Site H3
was similarly cloned into the 30-UTR of the Renilla luciferase
gene in the psiCHECK-2 vector in both orientations
(Supplementary Figure S2). Reporter plasmids were co-
transfected into HCT116 cells with various concentrations
of H3 RNA duplexes and luciferase activity was assayed 24
h post-transfection (Figure 3B). In this case, the 21mer duplex
demonstrated preferential targeting of the antisense target,
indicative of a ‘poor’ siRNA site. Both 27mers again showed
improved potency relative to the 21mer duplex. The antisense
strand was more efficiently suppressed relative to sense strand
for both ‘R’ and ‘L’ form 27mers, however the relative ratio
of strand targeting was markedly different between forms,
with the ‘L’ form duplex being significantly more potent
for antisense strand suppression.
Asymmetric Dicer–substrates duplexes having a 2-base
30-overhang on the antisense strand (with Dicer processing
proceeding to the right) generally show greater potency than
duplexes having the 30-overhang on the sense strand (with
Dicer processing proceeding to the left). This asymmetry
appears to result from a relative advantage of the antisense
strand for incorporation into RISC from the ‘R’ form while the
‘L’ form favors sense strand incorporation. In addition to
conferring greater functional potency, these findings also
suggest that off-target effects arising from the sense strand
may be reduced by using ‘R’ form duplexes.
Structural features that influence potency
of Dicer–substrate RNAs
The EGFP-hnRNPH assay system was used to study additional
aspects of duplex design. DNA residues were found to be less
favorable than RNA for Dicer processing of blunt 30 ends and
altered dicing patterns (Supplementary Figure S1). DNA resi-
dues were substituted for RNA in the 2-base 30-overhang of the
asymmetric ‘R’ version duplexes at both the H1 and H3 sites.
These duplexes were co-transfected with the EGFP-hnRNPH
reporter vector and EGFP expression was measured at 48 h
(Figure 4A). DNA bases in the 30-overhang reduced potency
2- to 3-fold compared with the original RNA-overhang
versions. Thus DNA bases can be incorporated in the single-
stranded 30-overhang (with some loss of activity) if increased
nuclease stability is needed, such as for in vivo applications.
The effect of varying the 30-overhang length was also tested
(Figure 4B). Asymmetric ‘R’ duplexes at site H3 having
1-base, 2-base, 3-base and 4-base RNA 30-overhangs all had
similar potency. Extremely long 30-overhangs of 17–20 bases
were shown to block dicing from that end and reduce potency
in triggering RNAi (8).
It has become common practice to make 21mer siRNAs
with DNA ‘TT’ 30-overhangs without regard to complement-
arity with the target sequence. We observed that substitution of
DNA for RNA in the 30-overhang can reduce potency by 2- to
3-fold (Figure 3B). Elbashir varied sequence in both sense and
antisense strand 30-overhangs for a luciferase 21mer siRNA
and found that certain base substitutions resulted in as much
as a 5-fold reduction in potency. Perfect match ‘UG’ or related
‘UdG’, ‘UU’, or ‘TT’ sequences also worked well, and ‘TT’
performed best (41). Vermeulen compared the relative effici-
ency of 16 duplexes for cleavage in an in vitro dicing assay that
had every possible 2-base combination in a single asymmetric
30-overhang in a 61mer substrate (29). A 30-terminal rA base
was found to be favorable for dicing, however no correlation
with functional potency was made. Dinucleotide overhang
sequences that are favorable for cleavage (Dicer substrates)
may be different from sequences that are favorable for func-
tional performance in 21mers (Dicer products). The effect
that base sequence of the 30-overhang may have on functional
potency of 27mer Dicer–substrate duplexes was tested.
A set of 16 asymmetric ‘R’ form duplexes were synthesized
at site H-3 in hnRNPH comprising every possible dinucleo-
tide pair in the single 2-base 30-overhang. Duplexes were
transfected into HEK293 cells with the Luc-hnRNPH-‘S’
reporter construct and assayed 48 h post-transfection for
luciferase activity (Figure 4C). The overhang sequence had
a significant impact on duplex potency, with the duplex
having a perfect match ‘UU’ overhang being 2–5 times more
potent than the other duplexes tested. Overhang sequences
that improved the efficiency of in vitro dicing of a 61mer
duplex RNA (29) performed poorly in our functional assay
of Dicer–substrate 27mer duplexes in suppressing target gene
expression. More sequence sets will need to be compared to
determine if complementary overhangs in the antisense strand
will generally perform better or if the ‘UU’ sequence itself
confers some advantage.
We have developed improved design criteria for short
Dicer–substrate RNA duplexes for use as triggers of RNAi.
Optimized design features include (i) asymmetric duplex with
a single 2-base 30-overhang on the antisense strand (‘R’ form
duplex, 25D/27 type), (ii) use of RNA bases in the 30-overhang
complementary to the target and (iii) substitution of two DNA
bases at the 30 end of the sense strand (blunt end). By exploit-
ing the substrate preferences for human Dicer, this design
generally leads to a single, predictable cleavage product after
dicing and invokes the functional polarity conferred by the
dicing reaction to favor antisense strand entry into RISC with
enhanced sense strand targeting.
Figure 4. Structure–activity features of Dicer–substrate RNA duplexes. (A) Comparison of activity of ‘R’ form 27mer duplexes with RNA versus DNA bases in the
single 2-base 30-overhang. (B) Comparison of activity of ‘R’ form 27mer duplexes with 1, 2, 3 or 4-base RNA 30-overhangs. (C) Comparison of activity of ‘R’ form
27mer duplexes with every possible RNA 2-base 30-overhang. Top: For A and B, an EGFP-hnRNPH fusion protein expression plasmid was transfected into cells
without (control) or with the indicated RNA duplexes and EGFP fluorescence was measured at 48 h post-transfection. For C, a luciferase expression vector containing
hnRNPH sequence in the 30-UTR was transfected into cells without (control) or with the indicated RNA duplexes and luciferase activity was assayed 48 h post-
transfection. Bottom: hnRNPH target sequence (S strand) is shown and duplexes employed in transfection are aligned beneath in duplex form with sense strand top
(50!30) and antisense strand bottom (30!50). RNA bases are upper case, DNA bases are lower case bold, and ‘p’ represents 50-phosphate. Two neighboring sites were
targeted, H-1 and H-3 shifted by two bases along the hnRNPH sequence.
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DISCUSSION
Degradative RNAi occurs through a complex series of linked
biochemical events involving a large number of protein com-
ponents, many of which are still being identified. The overall
process can be conceptualized as occurring in three stages,
including (i) processing of long dsRNAs into short 21–23mer
functional siRNAs, (ii) assembly of a mature RISC and (iii)
sequence-specific cleavage of target ssRNA (i.e. mRNA)
followed by degradation. In the initiator phase, long dsRNAs
are processed by Dicer into short 21–23mer siRNAs which
have 2-base 30-overhangs and 50-terminal phosphate groups
(10). In cell extracts, this process is accelerated by ATP (9,10);
however, recombinant human Dicer is ATP-independent (42).
In Drosophila, the potency of dsRNA to trigger an RNAi res-
ponse decreases as length is shortened from 130 to 29 bp (8).
Recombinant human Dicer efficiently cleaves long dsRNAs
but shows some loss of activity as the dsRNA substrate
decreases from 100 to 50 bp length (43). Shorter sequences
regain activity and, in fact, RNA duplexes as short as 23mer
length are substrates for human Dicer (cleaved to 21–22mer
products) (1). More than one Dicer molecule can bind a 130 bp
dsRNA molecule (possibly one on each end). Processing
preferentially begins by cleaving duplexes at their ends and
eventually results in complete degradation into 21–23 base
fragments (42). It is not clear if sequential cleavage events
occur in a processive fashion along a single substrate RNA
molecule or if Dicer cleaves, dissociates and re-binds the
substrate before cleaving again.
Dicer is a complex 220 kDa protein comprising a dsRNA
binding domain (dsRBD), a PAZ domain, a DExH RNA
helicase/ATPase domain, and two RNase III class domains
(42,43). The RNase III domains cooperatively function to
cleave substrate dsRNA into smaller 21–23 base fragments
and orientation for this cleavage is assisted by flanking dsRNA
binding domains, dsRBD and PAZ (33). Crystal structure of
the PAZ domain from human Argonaute eIF2c1 has been
determined and suggests that this element specifically func-
tions as a binding site for 2-base 30-overhangs (44). Similar
conclusions were made for the Drosophila Ago-2 protein
based upon NMR solution structure (45). The PAZ/PIWI
domains seem to serve as anchors that helps spatially oriented
bound RNAs in the enzyme active site (46,47). Argonaute
cleaves the substrate RNA 10 bases away from the PIWI
anchor site whereas Dicer cleaves 21–22 bases away from
the PAZ anchor site. This model fits well with our experi-
mental observations of dicing patterns for 27mer dsRNA sub-
strates. Blunt 27mer substrates do not provide an optimal
structure for binding the Dicer PAZ domain so the ‘anchor’
step takes place with imprecision and results in heterogeneous
cleavage products. Asymmetric duplexes with a single 2-base
30-overhang provide a single favorable PAZ binding site, so
these substrates usually have a single unique anchor site and
cleavage occurs 21–22 bases away with limited heterogeneity.
The presence of a 30-overhang promotes ‘correct’ dicing of
hairpin RNA substrates (21). Interestingly, the actual base
sequence of the 30-overhang can influence dicing (29) and
not all asymmetric duplexes with a single 30-overhang show
a simple dicing pattern (EGFPS2 R 27/25, Figure 1C). Adding
DNA residues to the blunt end of an asymmetric duplex
seems to help direct binding to the 30-overhang even for
‘unfavorable’ sequences, possibly because the presence of
DNA makes the blunt end an even worse structure for PAZ
binding (EGFPS2 R 27/25D, Figure 1D). Thus, asymmetric
duplexes with one 2-base 30-overhang in combination with
30-DNA residues on the blunt end present Dicer with a
substrate that is cleaved into predictable products.
Functional interpretation of the ESI-MS dicing data
assumes that the cleavage properties of endogenous human
Dicer will parallel the patterns observed using purified recom-
binant human Dicer in vitro. In Drosophila, Dicer functions
as a heterodimer with the RNA binding protein R2D2, which
forms a complex with Dicer and the siRNA duplex (48).
A possible human ortholog for R2D2 has recently been iden-
tified as TRBP (49). SiRNA-mediated depletion of TRBP
resulted in loss of recruitment of Ago-2 and destabilization
of Dicer. Behavior of human Dicer in vitro in the absence of
other RNAi pathway proteins such as TRBP may be different
from its properties in vivo. Since the actual functional potency
of RNA duplexes when transfected into cells follows predic-
tions made based upon dicing patterns obtained for the same
duplexes in vitro, it seems unlikely that in vivo dicing patterns
will be significantly different from those observed in vitro.
Dicer plays more than one role in the RNAi pathway.
In addition to endonuclease cleavage of long dsRNA into
siRNAs, Dicer is involved with entry of the siRNA into
RISC and participates in RISC assembly (25). Drosophila
has two Dicer proteins, a Dicer-1 nuclease that is involved
in miRNA processing and a Dicer-2 nuclease that is involved
in siRNA processing (22). Mutants lacking Dicer-2 activity
have defective RISC assembly, even when provided with
21mer siRNAs that do not require cleavage (23). We theorize
that the RISC assembly function of Dicer is involved with
the increased potency seen for Dicer–substrate RNA duplexes
compared with short 21mer siRNAs; providing Dicer with a
‘substrate’, rather than a ‘product’, may improve efficiency of
the RISC entry step.
While association with Dicer is required for entry of
siRNAs into RISC in Drosophila, the pathways available
for RISC loading may be slightly different in mammals. In
one study, single-stranded RNA was shown to be capable of
directing sequence-specific target cleavage via RNAi path-
ways in HeLa cell extracts while only duplex siRNAs could
direct target cleavage in Drosophila extracts. Further, immun-
odepletion of Dicer from the HeLa cell extracts did not block
target cleavage triggered by siRNAs (50). In another study,
a mouse ES cell line was established that was homozygous
for disruption of the dcr-1 gene and had no functional Dicer
activity. As expected, these cells were deficient for miRNA
production and could not initiate an RNAi response from
shRNA compounds, both of which require Dicer processing.
Unlike the Drosophila Dicer-2 mutants, however, the Dicer-
deficient mouse cells could support RNAi if provided exo-
genous 21mer duplex siRNAs (51). Thus two independent
studies suggest that Dicer is not required for siRNA entry
into RISC in mammalian cells. However, Dicer may still
play some role in siRNA loading into RISC. In studies per-
formed in both human and mouse cells, Doi and colleagues
demonstrated that knockdown of Dicer using RNAi triggered
by 21mer siRNAs significantly reduced the efficiency of
siRNA-mediated silencing of a luciferase reporter target (52).
In a study that reconciles some of the apparent differences
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between the human and Drosophila systems, Chendrimada
et al. (49) reported that RNAi-mediated knockdown of either
Dicer or TRBP, the proposed human R2D2 ortholog, reduced
efficiency of siRNA-mediated silencing of a luciferase
reporter target in a human cell line. Taken together, these
studies suggest that RISC loading and functional triggering
of an RNAi response is more efficient when Dicer and TRBP
are present, even though Dicer is clearly not required for
siRNA loading into RISC in mammals.
The roles played by various protein and their interactions
with the siRNA during RISC assembly are currently better
defined in Drosophila than in mammals. In Drosophila,
cooperative interaction of the R2D2 protein and Dicer-2 is
required for entry of a siRNA into RISC (48). R2D2 prefer-
entially binds the end of the siRNA duplex having greater
thermodynamic stability and specifically associates with the
50 end of whichever strand is present at this end. Conversely,
Dicer binds the 50 end of the strand on the opposing end (24).
This complex is joined by a variety of other protein compon-
ents as RISC assembly proceeds. Eventually, the siRNA
duplex is unwound and R2D2 exits RISC with its associated
single-strand (the ‘passenger strand’), leaving Dicer and its
associated strand in RISC. The retained strand later serves to
direct sequence-specific targeting (the ‘guide strand’). Ago-2
replaces R2D2 at the 30 end of the retained guide strand (24)
and is the Argonaute protein family member that functions as
the actual ‘slicer’ endonuclease activity in RISC (53).
Thermodynamic bias leads to preferential association of
R2D2 on one end of an siRNA duplex and Dicer on the
other end, and thereby directs as to which strand remains in
RISC (‘guide strand’) and which strand is ejected (‘passenger
strand’). The terminal base sequence therefore plays a signi-
ficant role in determining sense versus antisense strand target-
ing. Other factors may also influence which strand enters
RISC. Elbashir observed that the orientation of Dicer pro-
cessing of a model 52mer RNA duplex defined which strand
directed target cleavage. Long single-stranded overhangs
block dicing from starting at that end. A blunt 52mer duplex
directed cleavage of both sense and antisense strand targets.
A 52mer duplex with 20 base overhangs on both ends was
inactive and did not direct cleavage of either strand targets.
Asymmetric 52mer dsRNA duplexes showed strand bias. If the
20-base 30-overhang extended from the sense strand, Dicer
processing started from the blunt end and antisense strand
sequence preferentially directed cleavage of a sense target.
Conversely, if the 20-base 30-overhang extended from the
antisense strand, Dicer processing started from the blunt end
and sense-strand sequence preferentially directed cleavage of
an antisense target (8).
The difference of functional potency that we see between
‘R’ versus ‘L’ version asymmetric Dicer–substrate duplexes
probably relates to interactions between the same protein com-
ponents within the RNAi pathway. In the case of asymmetric
27mers, the blunt end is unfavorable for Dicer binding and
the dicing process starts at the end with a 2-base 30-overhang.
For ‘L’ duplexes, the 30-overhang resides on the sense (top)
strand. For ‘R’ duplexes, the 30-overhang resides on the anti-
sense (bottom) strand. ‘R’ duplexes generally show increased
potency in directing silencing of sense-strand targets, a pattern
consistent with the observations of Tuschl and co-workers (8).
In the model of RISC formation proposed by Zamore and
co-workers (24), Dicer associates with the 50 end of the strand
that is retained in RISC and R2D2 associates with the 50 end
of the discarded passenger strand. The recent discovery of
the required role for TRBP in mammalian RNAi opens the
possibility that this protein serves a function similar to the
Drosophila R2D2 (49). For 21mer siRNAs, where no dicing
occurs, thermodynamic end stability might be the dominant
factor directing which protein binds which end. For longer
dsRNAs, where dicing occurs, polarity of the dicing reaction
may also affect final protein binding patterns. Binding of a
30-overhang may spatially orient the siRNA cleavage product
in the correct position for association of the 50 end of that
strand with Dicer (and therefore remain in RISC) and allow
access of the other end to associate with a human R2D2 ortho-
log. This model assumes that some fraction of Dicer/siRNA
complexes remain intact following cleavage and directly enter
a developing RISC complex. If Dicer freely dissociated from
the siRNA product after cleavage and later rebound on the
basis of thermodynamic end stability, then polarity of the
dicing reaction should not influence potency or confer strand
bias. The nascent siRNA produced by Dicer cleavage has
symmetric 2-base 30-overhangs. Any effects introduced by
structure of the asymmetric substrate should be lost if product
siRNA and Dicer separate. This model is also consistent with
the pattern of increased potency observed for asymmetric short
siRNAs by Khvorova and co-workers (29). Here, binding of an
antisense-strand 30-overhang by the PAZ domain may simil-
arly serve to favorably orient the 50 end of the antisense strand
within Dicer for subsequent retention in RISC, in this case
without the need for a cleavage event.
Strand bias introduced by Dicer processing of asymmetric
duplexes confers a relative, not absolute, advantage to reten-
tion of the 30-overhang strand in RISC. For example, the strand
targeting experiments shown in Figure 3 demonstrate that use
of the ‘R’ versus ‘L’ form duplexes significantly alter the ratio
of ‘S’ versus ‘AS’ strand targeting; however, in all cases tested
both ‘S’ and ‘AS’ strand targeting still occurs. In a more
biologically relevant example, the active strand in miRNAs
can be derived from either the top or bottom strand of the
precursor miRNA and strand selection seems to be primarily
determined by thermodynamic asymmetry rules without
regard for the direction of Dicer processing (54). The relative
contribution of various factors that contribute to preferential
strand loading into RISC is complex.
Use of thermodynamic end stability rules (38,40,55)
and empiric design parameters (28,56) has helped speed wide-
spread use of RNAi in mammalian biology by making more
potent reagents easier to obtain. The asymmetric duplexes
described here similarly improve design of Dicer–substrate
RNAs by exploiting the functional polarity introduced by
Dicer processing.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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